Skip to content

The Effects Of Desflurane And Sevoflurane On Nesfatin1 Levels In Laparoscopic Cholecystectomy

The Effects Of Desflurane And Sevoflurane On Nesfatin1 Levels In Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617001023347
Enrollment
40
Registered
2017-07-14
Start date
2017-02-01
Completion date
2017-03-01
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Forty patients with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy between 01.03.2017 and 01.04.2017 were included in the study. The groups were randomly and equally identified by drawing group names from an envelope prior to anesthesia induction. For anesthesia maintenance, patients were randomly assigned to two groups. Patients in the first group received 40% O2, 60% air and desflurane (MAC 6%) (Forane, Abbott Lab., England). Patients in the second group received 40% O2, 60% air and sevoflurane (MAC2%). Patients in both groups received remifentanil infusion (0.25 microgram/kg/min) to maintain anesthesia. At the end of the surgery, all patients received 0.5 mg atropine and 1.5 mg neostigmine for decurarization. Hemodynamic and respiratory parameters (SAP, DAP, MAP, HR, SpO2, etCO2) were recorded before induction, after induction, after entubation, and during extubation. Blood samples were collected before induction (T1), and after extubation when aldrate score was 10 (T2). Blood samples were collected into aprotinin and EDTA-containing tubes. Samples were centrifuged at 3,000 rpm, and plasma samples were aliquoted in polypropylene tubes, and stored at -80 C until further analysis. Five cc of venous blood samples were used to analyze nesfatin-1 levels, by using a commercial ELISA kit according to the vendor’s instructions. (Ray- Biotech, Norcross, GA, USA; catalogue no. EIANES-1). In the present study, we aimed to analyze the changes in nesfatin levels in patients undergoing laparoscopic cholecystectomy based on postoperative surgical stress responses, and to compare the effect of two different inhaled agents on peripheral nesfatin levels.

Interventions

The groups were randomly and equally identified by drawing group names from an envelope prior to anesthesia induction. Heart rate (HR), mean systolic and diastolic arterial pressures (SAP, DAP, MAP), peripheral O2 saturation (SpO2) of the patients who were taken to the operation were monitorized. A 20-gauge (G) branule was used to enable intravenous access, and 0.9% sodium chloride (5-10 mL/kg/h) was infused. To induce anesthesia, the patients were given 1 mg of lidocaine (Aritmal, 2%, Osel), 1

The groups were randomly and equally identified by drawing group names from an envelope prior to anesthesia induction. Heart rate (HR), mean systolic and diastolic arterial pressures (SAP, DAP, MAP), peripheral O2 saturation (SpO2) of the patients who were taken to the operation were monitorized. A 20-gauge (G) branule was used to enable intravenous access, and 0.9% sodium chloride (5-10 mL/kg/h) was infused. To induce anesthesia, the patients were given 1 mg of lidocaine (Aritmal, 2%, Osel), 1 µg/kg of remifentanil (Ultiva, 5 mg, GlaxoSmithKline), 8 mg/kg of thiopental sodium, and 0.6 mg/kg of rocuronium bromide intravenously. After a three-min preoxygenation with 100% O2 administration through a face mask, orotracheal intubation was performed when sufficient muscle relaxation was observed. Then, patients were ventilated with a Drager anesthesia instrument (Luebeck, Germany), with tidal volume set to 10 mL/kg and frequency set to 12/min. Soda lime (Sorbo-lime, Berkim, Turkey) was used as a CO2 absorbant. For anesthesia maintenance, patients were randomly assigned to two groups. Patients in the first group received inhalation of 6 % desflurane in 60% O2, 40% air (Forane, Abbott Lab., England). Patients in the second group received 2% sevoflurane in 60% O2, 40% air. Patients in both groups received remifentanil infusion (0.25 µg/kg/min) to maintain anesthesia. At the end of the surgery, all patients received 0.5 mg atropine and 1.5 mg neostigmine for decurarization. In all groups, patients received 0.5 mg atropine when heart rate was <40; 10 mg of ephedrine when MAP was <50, and the infusion dose was lowered. Patients received intravenous tramadol (1 mg/kg) and methochloropropamide (10 mg) 30 min before the end of surgery. Hemodynamic and respiratory parameters (SAP, DAP, MAP, HR, SpO2, etCO2) were recorded before induction, after induction, after entubation, and during extubation. Blood samples were collected before induction (T1), and after extubation when aldrate score was 10 (T2). Blood samples were collected into aprotinin and EDTA-containing tubes. Samples were centrifuged at 3,000 rpm, and plasma samples were aliquoted in polypropylene tubes, and stored at -80 C until further analysis. Five cc of venous blood samples were used to analyze nesfatin-1 levels, by using a commercial ELISA kit according to the vendor’s instructions. (Ray- Biotech, Norcross, GA, USA; catalogue no. EIANES-1).

Sponsors

Ataturk Training and research hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

40-65 years with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy

Exclusion criteria

ASA3-4 RENAL FAILURE HEPATIC FAILURE

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 7, 2026